Citadel Advisors’s Aceragen Inc ACGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-41
Closed -$245 15905
2022
Q4
$245 Buy
+41
New +$246 ﹤0.01% 14713
2022
Q2
Sell
-606
Closed -$5K 14554
2022
Q1
$5K Sell
606
-4,293
-88% -$38.8K ﹤0.01% 13430
2021
Q4
$47K Sell
4,899
-2,379
-33% -$31.9K ﹤0.01% 13286
2021
Q3
$127K Buy
7,278
+1,437
+25% +$25.9K ﹤0.01% 12578
2021
Q2
$119K Sell
5,841
-571
-9% -$11.5K ﹤0.01% 12756
2021
Q1
$142K Buy
6,412
+5,753
+873% +$431K ﹤0.01% 12118
2020
Q4
$41K Buy
+659
New +$37.8K ﹤0.01% 10641
2018
Q2
Sell
-77
Closed -$19K 9426
2018
Q1
$19K Buy
+77
New +$21.1K ﹤0.01% 8134
2017
Q1
Sell
-154
Closed -$31K 8200
2016
Q4
$31K Buy
154
+33
+27% +$7.87K ﹤0.01% 6985
2016
Q3
$42K Buy
+121
New +$32K ﹤0.01% 6886
2016
Q2
Sell
-101
Closed -$27K 7565
2016
Q1
$27K Buy
101
+58
+135% +$15.5K ﹤0.01% 6399
2015
Q4
$18K Sell
43
-3
-7% -$1.34K ﹤0.01% 8012
2015
Q3
$21K Buy
46
+21
+84% +$9.29K ﹤0.01% 8134
2015
Q2
$13K Sell
25
-166
-87% -$76.2K ﹤0.01% 8335
2015
Q1
$96K Buy
191
+115
+151% +$70.1K ﹤0.01% 6870
2014
Q4
$45K Sell
76
-101
-57% -$40.5K ﹤0.01% 7271
2014
Q3
$55K Buy
177
+65
+58% +$23.4K ﹤0.01% 6852
2014
Q2
$44K Sell
112
-38
-25% -$15.7K ﹤0.01% 6844
2014
Q1
$83K Buy
+150
New +$103K ﹤0.01% 6364

Other funds holding ACGN

Citadel Advisors's ACGN Position: Q1 2023 in Review

Citadel Advisors sold out of Aceragen Inc (ACGN) in Q1 2023, closing a stake of 2,960 shares — an estimated $17.6K sold.

Citadel Advisors first reported a position in ACGN in Q1 2014 and held it in 26 quarters. The position peaked at $673K in Q1 2014. 19 funds tracked by Wall St. Rank hold ACGN as of Q1 2023.

  • Citadel Advisors reported no remaining Aceragen Inc position as of Q1 2023 after selling out during the quarter.
  • Citadel Advisors sold 2,960 Aceragen Inc shares in Q1 2023, an estimated $17.6K.
  • Citadel Advisors first reported a position in Aceragen Inc in Q1 2014 and held it in 26 quarters.
  • Citadel Advisors's Aceragen Inc position peaked at $673K in Q1 2014.
  • 19 funds tracked by Wall St. Rank held Aceragen Inc as of Q1 2023.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.